ESC Professional Premium Access

Effect of eplerenone according to duration of heart failure in EMPHASIS-HF: It is never too late to start an MRA in HFrEF

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Presentation

About the speaker

Doctor Shingo Matsumoto

Toho University, Tokyo (Japan)
0 follower

5 more presentations in this session

Diuretic use and outcomes in patients with HFrEF: Insights from the VICTORIA trial

Speaker: Doctor J. Ezekowitz (Edmonton, CA)

Thumbnail

Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis

Speaker: Doctor D. Vukadinovic (Homburg, DE)

Thumbnail

Scar characterisation to predict arrhythmia and death in ischaemic cardiomyopathy: insights from the REVIVED trial

Speaker: Doctor H. Morgan (London, GB)

Thumbnail

Impact of integrated care in patients with heart failure with reduced ejection fraction: a report from the WARCEF trial

Speaker: Associate Professor M. Proietti (Milan, IT)

Thumbnail

A national heart failure initiative is associated with improved use of quadruple guideline-directed medical therapy

Speaker: Doctor A. Sauer (Kansas City, US)

Thumbnail

Access the full session

Insights from recent HFrEF trials 2

Speakers: Doctor S. Matsumoto, Doctor J. Ezekowitz, Doctor D. Vukadinovic, Doctor H. Morgan, Associate Professor M. Proietti...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb